We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here are four stocks with Zacks Rank #1 (Strong Buy) and strong momentum characteristics for investors to consider today, April 19th:
Applied Optoelectronics, Inc. (AAOI - Free Report) : This manufacturer and designer of optical devices has seen the Zacks Consensus Estimate for its current year earnings climbing 76.4% over the last 60 days.
DST Systems, Inc. : This technology-based information processing solutions provider has witnessed the Zacks Consensus Estimate for its current year earnings rising 2.3% over the last 60 days.
Chemours Company (CC - Free Report) : This chemical company has witnessed the Zacks Consensus Estimate for its current year earnings jumping 38.1% over the last 60 days.
Corvus Pharmaceuticals Inc (CRVS - Free Report) : This clinical-stage biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings soaring 5% over the last 60 days.
While today's Zacks Rank #1 new additions are being shared with the public, other trades are hidden from everyone but selected members. Would you like to peek behind the curtain and view them? Starting today, for the next month, you can follow all Zacks' private buys and sells in real time from value to momentum . . . from stocks under $10 to ETF and option moves . . . from insider trades to companies that are about to report positive earnings surprises (we've called them with 80%+ accuracy). You can even look inside portfolios so exclusive that they are normally closed to new investors. Click here for all Zacks trades >>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Top Ranked Momentum Stocks to Buy for April 19th
Here are four stocks with Zacks Rank #1 (Strong Buy) and strong momentum characteristics for investors to consider today, April 19th:
Applied Optoelectronics, Inc. (AAOI - Free Report) : This manufacturer and designer of optical devices has seen the Zacks Consensus Estimate for its current year earnings climbing 76.4% over the last 60 days.
Applied Optoelectronics, Inc. Price and Consensus
Applied Optoelectronics, Inc. Price and Consensus | Applied Optoelectronics, Inc. Quote
Applied Optoelectronics’ shares gained more than 100% in the last three months. The company possesses a Momentum Score of A.
Applied Optoelectronics, Inc. Price
Applied Optoelectronics, Inc. Price | Applied Optoelectronics, Inc. Quote
DST Systems, Inc. : This technology-based information processing solutions provider has witnessed the Zacks Consensus Estimate for its current year earnings rising 2.3% over the last 60 days.
DST Systems, Inc. Price and Consensus
DST Systems, Inc. Price and Consensus | DST Systems, Inc. Quote
DST Systems’ shares gained 9.1% over the last three months. The company possesses a Momentum Score of B.
DST Systems, Inc. Price
DST Systems, Inc. Price | DST Systems, Inc. Quote
Chemours Company (CC - Free Report) : This chemical company has witnessed the Zacks Consensus Estimate for its current year earnings jumping 38.1% over the last 60 days.
Chemours Company (The) Price and Consensus
Chemours Company (The) Price and Consensus | Chemours Company (The) Quote
Chemours’ shares gained 69.4% over the last three months higher. The company possesses a Momentum Score of A.
Chemours Company (The) Price
Chemours Company (The) Price | Chemours Company (The) Quote
Corvus Pharmaceuticals Inc (CRVS - Free Report) : This clinical-stage biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings soaring 5% over the last 60 days.
Corvus Pharmaceuticals, Inc. Price and Consensus
Corvus Pharmaceuticals, Inc. Price and Consensus | Corvus Pharmaceuticals, Inc. Quote
Corvus Pharmaceuticals’ shares rose about 37.7% over the past three month’s period. The company possesses a Momentum Score of A.
Corvus Pharmaceuticals, Inc. Price
Corvus Pharmaceuticals, Inc. Price | Corvus Pharmaceuticals, Inc. Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here
Now See All Our Private Trades
While today's Zacks Rank #1 new additions are being shared with the public, other trades are hidden from everyone but selected members. Would you like to peek behind the curtain and view them? Starting today, for the next month, you can follow all Zacks' private buys and sells in real time from value to momentum . . . from stocks under $10 to ETF and option moves . . . from insider trades to companies that are about to report positive earnings surprises (we've called them with 80%+ accuracy). You can even look inside portfolios so exclusive that they are normally closed to new investors. Click here for all Zacks trades >>